-
Vascular Health and Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Current management of type B aortic dissection
Review
(4724) Views (2084) Full article downloads
Authors: T Paul Tran, Ali Khoynezhad
Published Date October 2008
Volume 2009:5 Pages 53 - 63
DOI: http://dx.doi.org/10.2147/VHRM.S4205
T Paul Tran1, Ali Khoynezhad2
1Department of Emergency Medicine; 2Section of Cardiothoracic Surgery, University of Nebraska Medical Center, Omaha, NE, USA
Abstract: Acute aortic dissection is a life-threatening condition associated with high morbidity and mortality. In this article, the authors review basic biology of the aorta and aortic dissection, epidemiology, clinical presentation, diagnostic approach, emergency stabilization measures, and the latest surgical approach for type B dissection.
Keywords: acute aortic dissection, aorta, diagnosis, management, review
Readers of this article also read:
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Dronedarone for atrial fibrillation: a new therapeutic agent
Ankle Brachial Pressure Index (ABPI): An update for practitioners
Comparative assessment of angiotensin receptor blockers in different clinical settings
Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
Social facilitation in virtual reality-enhanced exercise: competitiveness moderates exercise effort of older adults
Safety and tolerability of exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trials
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The western diet and lifestyle and diseases of civilization
- Stiffness of the large arteries in individuals with and without Down syndrome
- Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study
- Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review




